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Abstract
Significant progress has been made in the prevention, control, and elimination of human parasitic diseases in China
in the past 60 years. However, parasitic diseases of poverty remain major causes of morbidity and mortality, and
inflict enormous economic costs on societies.
In this article, we review the prevalence rates, geographical distributions, epidemic characteristics, risk factors, and
clinical manifestations of parasitic diseases of poverty listed in the first issue of the journal Infectious Diseases of
Poverty on 25 October 2012. We also address the challenges facing control of parasitic diseases of poverty and
provide suggestions for better control.
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Background
Infectious diseases of poverty (IDoPs) are a series of
diseases closely related to poverty, which are mainly
prevalent in the least developed countries and regions
of the world [1–3]. Most IDoPs are neglected tropical
diseases, causing disabling chronic infections, and
even death [2]. In addition, IDoPs can result in huge
economic losses and make it more difficult for poor
people to improve their quality of life and social
status [3].
It has been estimated that IDoPs affect three billion
people worldwide, and they kill almost nine million
people each year, many of them are children under five
[3]. Factors such as climate change and population
migration have accelerated the spread of these diseases,
causing health and socioeconomic problems globally. It
is a vicious cycle: poverty due to endemic IDoPs
depresses economies in the affected communities by
reducing people’s ability to work. This in turn renders
the poor less able to pay for treatment and also aggra-
vates transmission of IDoPs [2–6].
Although tremendous achievements have been made
in fighting IDoPs in China in the past 60 years, the
sheer scale of the task means that the country still
accounts for a large percentage of the global burden of
disease due to IDoPs. For example, schistosomiasis
still affects at least a hundred thousand people in
China, and up to 90 % of the world’s burden of
alveolar echinococcosis is attributed to China, where
about 86 million people are at risk [7–9]. Of the 15
million people who are infected with Clonorchis
sinensis globally, over 85 % live in China [7–9].
In this review, our main objectives are to describe
the prevalence rates, geographical distributions, epi-
demic characteristics, risk factors, and clinical mani-
festations of parasitic diseases of poverty listed in
first issue of the journal Infectious Diseases of Poverty
on 25 October 2012, which have caused extensive
damage in China (see Table 1) [1]. We also discuss
the current challenges and strategies for controlling
these diseases.
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Table 1 Key characteristics of parasitic diseases of poverty in China
Disease Parasite Definitive host Intermediate host Factors relating to infectiona Clinical manifestations DALYsb (thousands)
Vector-borne diseases
Malaria [10–13] Plasmodium spp. Humans and
other animals
Mosquito Children, pregnant women, humble
house, lack of bed nets, immigrants
from epidemic regions, occupation
dependent exposure to mosquitoes
Fever, headache, shock, jaundice,
abnormal bleeding, nausea, vomiting,
diarrhea, anemia, hepatosplenomegaly
82 685
Leishmaniasis [26–28] Leishmania spp. Humans and
other mammals
Sandfly Children, the older, males, dog
ownership, herdsman, humble
house, sleeping outside, occupation
dependent exposure to sandfly
CL: Skin papules, plaque, ulcer and
nodular prurigo
ML: Edema and erythema on nose,
nasal stuffiness or bleeding,
mucosal lesions
VL: Fever, weight loss, anemia,
hepatosplenomegaly
3 317
Lymphatic filariasis [31–33] Wuchereria bancrofti
Brugia malayi
Brugia timori








Schistosomiasis [35–37] Schistosoma spp. Humans and
other mammals
Oncomelania hupensis Males, high frequency of water
contact, occupation dependent
exposure to snails, snails
related practices
Fever, headache, abdominal pain,










Males, the older, high frequency











Children, high frequency of
eating of raw or undercooked
freshwater crabs








Water snails Children, females, high frequency
of eating of raw vegetables or
untreated water and contact
with ruminants





Ascariasis Ascaris lumbricoides Humans - Ascariasis and trichuriasis:
school-aged children
Hookworm: the older and farmers
Inappetence, undernutrition,
abdominal pain, diarrhea, anemia,
growth and cognitive deficits
1 315
Trichuriasis Trichuris trichiura Humans - 638
Hookworm [63–66] Ancylostoma duodenale
Necator americanus
Humans - 3 231
Enterobiasis [66, 70, 72] Enterobius vermicularis Humans - School-aged children, crowded Inappetence, restlessness, perianal


























Pigs related practices, high
frequency of eating of raw pork













Females, the older, herdsmen
slaughter and viscera disposal
practices, dog related practices
AE: Tumour-like multi-vesicular
CE: Unilocular fluid-filled bladders
144
Water-borne diseases
Cryptosporidiosis [88–90] Cryptosporidium spp. Humans and
other animals
- Children, immunocompromised




Giardiasis [95] Giardia spp. Humans and
other animals
- Children, poor water treatment Diarrhea, malnutrition, growth
deficits, weight loss
-
Toxoplasmosis [98–101] Toxoplasma gondii Felids Humans and
other animals

















aPoverty, poor sanitation and inadequate hygiene and poor knowledge of, attitudes towards and practice relating to parasites are also the predisposing factors to these diseases. bSource: WHO, Global Burden of

















Malaria, one of the most threatening diseases worldwide,
is endemic in over 100 developing countries, with about
58 % of deaths due to malaria occurring in poor com-
munities [10–13]. Five species of the genus Plasmodium
commonly infect human beings. Plasmodium falciparum
and P. vivax cause the majority of infections, with most
malaria deaths caused by P. falciparum. Both of these
species may cause abortion and intrauterine growth
retardation if infection occurs during pregnancy. The
species P. ovale, P. malariae, and P. knowlesi can also
infect humans but are uncommon, and do not manifest
in serious symptoms [10–13].
Although significant progress has been made in redu-
cing the malaria burden, there were still 198 million
malaria cases worldwide in 2013, causing 584 000 deaths
[14–16]. In China, malaria, mainly due to P. falciparum
and P. vivax can be traced back 4 000 years. Before the
foundation of the People’s Republic of China, malaria
threatened 75 % of the Chinese population: over 30
million cases were recorded annually with about a 1 %
mortality rate. Since 1949, the overall burden of malaria
has been markedly reduced and endemic regions have
greatly reduced in area (see Table 2) [17–22]. However,
this ancient disease still represents a serious public
health challenge in China, and some new problems are
emerging. Before 2012, P. vivax was the major species of
malaria parasite in China. Despite the lower mortality
caused by this species, it is a major cause of morbidity.
After the National Malaria Elimination Programme was
launched in 2010, the incidence of locally transmitted P.
vivax malaria has declined, but numbers of imported P.
vivax and P. falciparum malaria cases have increased
significantly due to the large number of migrant workers
and travelers coming into China. P. falciparum has be-
come the major imported species of malaria (see Table 2)
[17–23]. Antimalarial drug-resistant Plasmodium spp.
emerged in some endemic areas and global warming
has lead to an expansion of the habitats of mosqui-
toes [24]. These factors are making it more challen-
ging to achieve the goal of eliminating malaria by
2020 throughout the entire country, but with contin-
ued efforts and new surveillance-response systems,
the goal can be achieved.
Leishmaniasis
Leishmaniasis is highly prevalent in poor countries in
Southeast Asia, East Africa, and Latin America. The
disease is present in 88 countries, resulting in 1.5–2
million new cases each year [25]. The three different
forms of leishmaniasis are cutaneous leishmaniasis (CL),
mucosal leishmaniasis (ML), and visceral leishmaniasis
(VL) [26–28]. VL, the most severe form, is caused by
Leishmania donovani or L. infantum, and falls into three
different epidemiological types in China: the anthropo-
notic type, the zoonotic mountain type, and the zoonotic
desert type [28]. It was once highly prevalent and ram-
pant in areas north and northwest of the Yangtze River,
especially in the rural regions of Shandong, Jiangsu,
Anhui, and Henan provinces. In 1951, about 530 000 VL
cases occurred across more than 650 counties in at least
16 provinces/autonomous regions/municipalities (P/A/

















2011 4 479 (3 658 laboratory
confirmed cases and 821
clinically diagnosed cases)
33 0.0334/10 000 27.4 % (782/2 856) P. falciparum: 40.2 %
P. vivax: 56.7 %
P. ovale or
P. malaride: 1.9 %
Mixed infection: 1.1 %





2012 2 718 (2 599 laboratory
confirmed cases and 119
clinically diagnosed cases)
15 0.0202/10 000 21.7 % (620/2 853) P. falciparum: 54.6 %










2013 4 128 (4 087 laboratory
confirmed cases and 41
clinically diagnosed cases)
23 0.0305/10 000 21.2 % (605/2 852) P. falciparum: 71.2 %
P. vivax: 22.8 %
P. ovale or
P. malaride: 4.5 %
Mixed infection: 1.6 %





2014 3 078 (3 057 laboratory
confirmed cases and 21
clinically diagnosed cases)
25 0.0226/10 000 23.8 % (680/2 853) P. falciparum: 61.6 %
P. vivax: 27.7 %
P. ovale or
P. malaride: 9.3 %
Mixed infection: 1.4 %
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Ms) in China. National control programs undertaken in
the 1950s aimed at exterminating the sandfly vector,
curing infected dogs, and treating patients. Since then,
the disease has been effectively controlled and almost
eliminated in eastern and northern China. The number
of VL cases decreased to 360 in 1990, with some spor-
adic cases reported in six provinces in the central and
western China: Xinjiang Uygur and Inner Mongolia
Autonomous Regions, and Gansu, Sichuan, Shaanxi, and
Shanxi provinces. However, transmission in these prov-
inces was never completely interrupted and the number
of VL cases has increased from 2003 to 2009. The
number of areas of transmission has expanded in recent
years due to population movement and ecological
changes. This might explain the outbreak of VL in Jiashi
county, Xinjiang Uygur in 2009 [28, 29]. A total of 3601
cases were officially reported between 2004 and 2014 in
China, varying from 158 to 509 cases per year. There
was a sharp increase in 2008 and 2009, with an inci-
dence of 0.0169/100 000 in 2009 [30]. More than 97 %
of these cases were concentrated in Xinjiang Uygur,
Gansu, and Sichuan, where reservoirs of Leishmania and
sandfly vectors remain common [30].
Lymphatic filariasis
Lymphatic filariasis is caused by three closely-related
filarial nematodes: Wuchereria bancrofti, Brugia malayi,
and B. timori. This disease affects more than 120 million
people worldwide, about 40 million of them are disabled
and disfigured [31–33]. Sixty years ago, lymphatic filaria-
sis was widely prevalent in mainland China, with 31
million cases and 330 million people at risk living in 864
endemic counties in 16 P/A/Ms, mainly in southeastern
China. Bancroftian filariasis accounted for about two-
thirds of these cases (~22 million) and nine million were
Brugian filariasis. Since then, excellent control measures
have been introduced, including treatment of infected
individuals with diethylcarbamazine (DEC) and the
distribution of DEC-fortified salt. The latter measure, in
particular, has been very effective for the control and
treatment of this disease. By 1980, basic elimination of
filariasis was achieved in many endemic counties. By
1994, all 864 endemic counties had reached the basic
elimination criteria and reduced the microfilaremia rate
to below 1 %. After decades of efforts in control and
surveillance of filariasis, China became the first devel-
oping country to eliminate lymphatic filariasis in 2007,
as verified by the World Health Organization [34].
However, there are still about 400 000 chronic cases
resulting from past infections in China, and there is
threat of imported infection. Therefore, China should
strengthen its surveillance-response system for this




Schistosomiasis causes substantial morbidity and mortal-
ity, enforcing a cycle of poverty, especially in already poor
rural communities. Three major species (Schistosoma
japonicum, S. haematobium, and S. mansoni) can infect
humans, with at least 230 million people in approximately
76 developing countries being afflicted [35, 36]. In
China, schistosomiasis due to S. japonicum, once a
widespread serious disease, has been recorded over the
past 2 100 years. In the 1950s, S. japonicum was
endemic in 12 P/A/Ms, with around 11.6 million people
infected and more than 100 million people at risk of
infection. It was estimated that over 1.2 million cattle
were infected and that suitable habitat for the snail
intermediate host (Oncomelania hupensis) covered an
area of 14.3 billion square meters. After the foundation
of the People’s Republic of China, the government
finally comprehended the enormous social and eco-
nomic losses due to S. japonicum and adopted a series
of prevention and control strategies against the disease.
These can be separated into three phases. During the
first phase (1950s to early 1980s), snail control was the
strategy used to limit transmission of schistosomiasis.
Environmental modifications and use of molluscicides
in snail habitats significantly reduced the prevalence of
the disease. In the second phase (mid-1980s to 2003),
large-scale chemotherapy and morbidity control were
implemented. Assisted by a World Bank loan, the wide-
spread mass administration of praziquantel reduced the
number of schistosomiasis cases from about 1 522 100
in 1989 to 865 000 in 1995. During the third phase
(2004 until now), an integrated strategy is being used to
reduce potential sources of infection. The intention is
to prevent the spread of S. japonicum eggs from the
feces of cattle and humans to snails. By 2008, the preva-
lence rate, both in humans and cattle, had decreased to
less than 5 % in all endemic counties [37–39]. The num-
ber of schistosomiasis cases fell from 842 525 in 2004 to
115,614 in 2014. The number of acute cases reduced from
816 in 2004 to two in 2014, and the extent of suitable
habitat for O. hupensis snails was reduced from 7 billion
square meters in 2004 to 3.64 billion square meters in
2014 [40, 41]. Some P/A/Ms, including Guangxi Zhuang
Autonomous Region and Shanghai, Zhejiang, Guangdong,
and Fujian provinces, have now achieved the national
criteria for elimination. However, schistosomiasis is still
endemic in Anhui, Jiangxi, Hunan, Sichuan, and Yunnan
provinces. Factors including global warning and popula-
tion movements have the potential to cause the reemer-
gence of schistosomiasis [40, 41]. Challenges such as lack
of effective tools for snail control, and the effect of climate
and ecosystem changes remain to be overcome if the goal
of schistosomiasis elimination by 2020 is to be achieved.
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Clonorchiasis
Clonorchiasis caused by Clonorchis sinensis is mainly
distributed in East Asia and leads to a significant disease
burden, with approximately 15 million people infected
[42, 43]. The most severe complication is cholangiocar-
cinoma [44]. In 2009, the International Agency of
Cancer Research classified C. sinensis as a group 1
carcinogen [45]. China accounted for the largest propor-
tion of clonorchiasis cases, with over 13 million people
infected in 2004 [43, 46]. From 1988 to 1992 and 2001
to 2004, two national surveys were conducted, respect-
ively, and indicated that the prevalence of clonorchiasis
has increased from 0.37 % in 30 P/A/Ms in 1992 to
0.58 % in 31 P/A/Ms in 2004 [47, 48]. The infection rate
and intensity of infection were higher in males than in
females and were reported to increase with age, peaking
at 50–59 years in 2004 [48]. There are two major
epidemic zones in China. The first is in northeastern
China and includes Heilongjiang, Jilin, and Liaoning
provinces. In Heilongjiang, a study of 4951 clinically
suspected outpatients between 2009 and 2012 confirmed
that 25.93 % had clonorchiasis, with the highest preva-
lence (34.25 % [437/1 276]) recorded in 2012 [49]. The
second zone includes Guangdong and Guangxi Zhuang
in Southern China [42, 43, 46]. Guangdong had the
highest prevalence (16.4 %) followed by Guangxi Zhuang
(9.8 %) in 2004 [48]. Surveys conducted in Hengxian
County, Guangxi Zhuang, between 1989 and 2011 and
in Guangzhou city, Guangdong between 2006 and 2012
found a trend towards increasing infection rates and
intensities [50, 51]. Many animals serve as reservoir
hosts for C. sinensis with potentially high prevalence
rates: 20.5 % in dogs and 41.8 % in cats recorded in
Guangdong in 2008 [52]. The Chinese government is
well aware of the importance of this disease and has take
some measures to control this disease such as the
prevention of contamination of fish ponds and aquacul-
ture systems by faeces, the control of snails, and the
implementation of education campaigns [53].
Paragonimiasis
Paragonimiasis, caused by lung flukes of the genus Para-
gonimus, is an important food-borne zoonosis. At least
10 of the >30 named Paragonimus species are known to
infect humans [42, 54]. About 40 % of the 56 million
food-borne trematode infections worldwide are caused
by Paragonimus spp.. The disease is endemic in Asia,
Africa, and the Americas [42, 54], but most cases
(~90 %) are distributed in Asia, and the majority of
those are in China [54]. The second national survey,
conducted in 2004, showed that the overall prevalence
of paragonimiasis in China was about 1.7 %, indicating
that about 22 million people were infected. In that
survey, Shanghai and Chongqing cities had the highest
infection rates (about 5.1 % and 4.1 %, respectively) [48].
In China, human paragonimiasis is mainly caused by
Paragonimus skrjabini and P. westermani, which use
freshwater snails as their first intermediate hosts. Many
species of crabs and crayfish can act as second inter-
mediate hosts. The prevalence of Paragonimus in the
first and second intermediate hosts can be high [54].
One small-scale survey conducted in Dazhou city, Sichuan
in 2013 found a 22.7 % prevalence of metacercariae in
crabs [55]. Although there have been no recent large-scale
surveys conducted on the disease in humans, some
small-scale surveys have indicated that prevalence of
paragonimiasis has not greatly diminished in the
country: e.g. rates of 3.6 % (30/840) in Dazhou and
2.6 % (35/1,373) in Xingshan county, Hubei province
were recorded in 2012 [55, 56].
Fascioliasis
Fascioliasis is caused by Fasciola gigantica and F. hepat-
ica. The distribution of these species is largely dictated
by the geographical ranges of the freshwater snail species
that act as intermediate hosts. Fasciola hepatica has a
near-global geographical distribution, whereas F. gigantic
occurs in tropical regions mainly in Africa and Asia [42].
Fascioliasis in livestock has always been well recognized
because of the enormous economic costs incurred due
to the disease [57]. It has been estimated that about 700
million production animals are at risk of infection, lead-
ing to an economic loss of over $2 billion per year. How-
ever, human fascioliasis has been markedly neglected,
with only about 2 500 human cases reported before the
1990s [57–59]. In the last 20 years, due to climate and
global changes, in some regions fascioliasis is emerging
or remerging in humans and animals, and several out-
breaks of human fascioliasis have been reported. It has
been estimated that millions of people, mainly in low-
income countries, are infected, with an additional 180
million at risk of infection [57].
In China, F. gigantica is endemic mainly in tropical and
subtropical regions such as Guangxi Zhuang, Guangdong,
and Yunnan, whereas F. hepatica occurs throughout the
country. Only 44 human fascioliasis cases were reported
before the 1990s [60]. According to the first national
survey conducted in 1992, 120 000 people were infected,
with regional prevalence rates ranging from 0.002 % to
0.017 %. Prevalence rates were highest in Gansu [47].
Sporadic human cases and outbreaks are reported from
time to time. For example, in Yunnan, 15 cases of F.
hepatica infection were reported in 2005, and 29 cases of
F. gigantica infection in 2012 [61]. High prevalence rates
have been reported in ruminants. For example, in Ili
Kazak Autonomous prefecture, Xinjiang Uygur, the preva-
lence of Fasciola infection in sheep was 42.7 % (983/2,300)
in 2011 [62]. In Yunnan, 28.6 % of cattle and 26.0 % of
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goats were infected with fascioliasis in 2012 [61].
Limited surveys about the prevalence of the disease
in humans and animals have hindered the design of
more effective control and surveillance systems in
the country.
Soil-transmitted helminths
Soil-transmitted helminths (STHs), mainly ascariasis,
trichuriasis, and hookworm infections, are nonlinearly
correlated with poverty and are highly prevalent in
developing countries, causing immense disease bur-
dens [63–66]. Over five billion people are at risk and
at least one billion are infected with at least one STH
species globally. Around 300 million people suffer
from severe morbidity. Ascariasis and trichuriasis,
caused by the ingestion of infective eggs of the
roundworm Ascaris lumbricoides and the whipworm
Trichuris trichiura, affect more than 800 million and
600 million people worldwide, respectively. Hookworm
infections, acquired by active penetration of the skin
by worm larvae in the soil, are caused by Ancylos-
toma duodenale and Necator americanus. Over 700
million people are infected and over 130 000 deaths
are caused annually from these infections [63–66].
The highest morbidity rates occur in the rural poor
and school-aged children.
In China, human infections with STHs were com-
mon in the past. However, after years of efforts using
control measures such as chemotherapy, sanitation,
and health promotion, the prevalence has decreased
significantly. The first national survey, conducted in
1992, revealed an overall prevalence of 47.0 %, 18.8 %,
and 17.2 % for ascariasis, trichuriasis, and hookworm,
respectively. The second national survey, conducted in
2004, found that the respective prevalence rates were
12.7 %, 4.6 %, and 6.1 %, a reduction of about 407
million infections [47, 48]. Prevalence rates and inten-
sities of STH infections continue to decline each year.
In 2010, the respective prevalence rates were further
reduced to 6.8 %, 1.8 %, and 3.7 % [67]. However,
some provinces still had high prevalence of STH infec-
tion such as 40.8 % in Hainan, 34.6 % in Guizhou, and
30.6 % in Sichuan in 2010 [67]. The prevalence rates
in some poor rural areas in these provinces are higher.
For example, a large-scale survey of 2179 children
aged 9–11 years living in impoverished rural areas in
Guizhou province showed that 42.0 % were infected
with at least one STH species in 2013 [68]. Another
survey revealed that the prevalence rates of STH infec-
tions in children of school age and below in poor rural
areas of Guizhou and Sichuan was 21.2 % and 22.9 %
in 2013, respectively [69]. Therefore, STH infections
are still a significant health problem for both children
and adults living in poor rural areas.
Enterobiasis
In addition to the three major STHs discussed above,
enterobiasis, caused by Enterobius vermicularis, is one of
the most highly prevalent parasitic diseases in children.
Enterobius vermicularis is the oldest and most widely
distributed pinworm affecting about 400 million people
worldwide (with 4–28 % of children infected globally)
[66, 70]. According to national surveys conducted in
China, the prevalence of E. vermicularis infection in
children has decreased from 23.6 % in 1992 to 10.3 % in
2004, and further to 6.6 % in 2010 [47, 48, 71]. Despite
overall reductions at the national level, however, infec-
tion rates in some endemic areas have actually increased.
The prevalence rate rose to 46.1 % in Guangdong in
2010 [70]. A recent survey of 802 children conducted in
Gaozhou city, Guangdong in 2011 showed a E. vermicu-
laris prevalence of 54.9 % [72].
Zoonotic parasitic diseases
Taeniasis and cysticercosis
Taeniasis and cysticercosis affect millions of people and
incur significant economic costs primarily in developing
countries. Humans, the obligate definitive hosts for the
species Taenia solium, T. asiatica, and T. saginata, har-
bor the adult tapeworm in the small intestine after
consumption of raw or undercooked pork or beef con-
taminated with cysticerci. The disease usually manifests
in symptoms such as mild abdominal pain and can even
be asymptomatic [73, 74]. However, people harboring
tapeworms shed eggs in their feces, which is a potential
source of infection for animals and humans. Human
cysticercosis is caused by the accidental ingestion of T.
solium eggs or via autoinfection. Infection of the human
central nervous system leads to neurocysticercosis, which
is considered to be the most frequent cause of acquired
epilepsy and seizures worldwide. At least 30 million
people have symptomatic neurocysticercosis, with 50,000
deaths recorded each year [73, 74].
In China, human taeniasis is caused by the three
Taenia species listed above. Over 550 000 people are in-
fected. Human cysticercosis is heavily endemic in China
because of the consumption of traditional pork products
[48]. According to two national surveys, the prevalence
rates of taeniasis and cysticercosis have increased signifi-
cantly. Taeniasis increased from 0.18 % in 1992 to
0.28 % in 2004, and cysticercosis from 0.01 % in 1992 to
0.58 % in 2004. The Tibet Autonomous Region had the
highest prevalence of taeniasis (19.2 %) and Shaanxi had
the highest prevalence of cysticercosis (3.4 %) in 2004
[47, 48]. Although in recent years, only small-scale
surveys of these infections have been conducted, and the
findings indicated that taeniasis and cysticercosis are still
endemic in China. One survey in 2007 showed that the
prevalence rates of taeniasis in Yajiang county, Sichuan,
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and Ming county, Gansu were 6.4 % (73/1,137) and
4.1 % (27/652), respectively, and the prevalence of
cysticercosis in Ming county was 2.6 % (17/652) [75].
Another survey conducted in Danba County, Sichuan
from 2008 to 2014 found a prevalence of 2.3 % (23/1
013) for cysticercosis. Tibetans have a habit of eating
uncooked meat, leading to a high incidence of cysticer-
cosis [76]. Some measures have been taken to control
these diseases such as toilet amelioration, inspection of
meat in the markets, and introduction of the intensive
rearing systems.
Echinococcosis
Human echinococcosis is increasingly considered to be
one of the most challenging problems for human and
animal health globally. Echinococcus granulosus and E.
multilocularis, the two major species infecting humans,
cause human cystic echinococcosis (CE) and alveolar
echinococcosis (AE), respectively. Geographically, CE
has a worldwide distribution, while AE is rare and lim-
ited to a few regions, located at relatively high latitudes
in the northern hemisphere [77–79]. The mortality rate
of AE is usually higher than that of CE. Globally, it has
been estimated that over three million people are
infected with Echinococcus [80, 81]. Echinococcosis is
heavily endemic in China, with 0.38 million people
infected, and accounting for 40 % of the global CE
disability-adjusted life years (DALYs) and more than
90 % of global AE DALYs [80, 81]. Recent epidemio-
logical studies indicate that echinococcosis is wide-
spread in the central and western regions of China
including Xinjiang Uygur, Inner Mongolia, and Ningxia
Hui Autonomous Regions, and Qinghai, Gansu, and
Sichuan provinces, and that prevalence rates appear to
have gradually risen in recent years. In China, human CE
cases are responsible for more than 90 % of echinococco-
sis infections, with AE cases forming the remainder. The
latter are spatially correlated with climate and landscape
characteristics. The prevalence of human AE was found to
decrease with the ratio of forests and increase with the
ratio of alpine meadows [82]. Seroepidemiological surveys
conducted in highly endemic areas of western China have
indicated a prevalence of echinococcosis of 5–30 % in




Cryptosporidiosis, caused mainly by Cryptosporidium
hominis and C. parvum, is one of the most common
causes of diarrhea and gastroenteritis in humans and
domestic animals [88–90]. Although globally distributed,
the prevalence of cryptosporidiosis in immunocompe-
tent individuals in low-income countries (5–10 %) is
higher than that in advanced economies (1 %). The
greatest burden of cryptosporidiosis occurs among chil-
dren and immunocompromised individuals [88–90]. In
China, since the first report of human cryptosporidiosis
in 1987, about 20 outbreaks have been reported. Crypto-
sporidiosis is endemic in at least 17 P/A/Ms with occur-
rence rates from 1.4 % to 10.4 %. Children and HIV/
AIDS patients are more susceptible to infection [91]. A
survey undertaken in 2008 showed that the prevalence
of Cryptosporidium spp. in HIV/AIDS patients was
10.1 % (8/79), which was significantly higher than the
3.1 % (9/294) recorded in the control population [92].
High prevalence rates of Cryptosporidium in domestic
animals have been reported in various areas. In addition
to leading to significant economic losses, this is also a
major risk factor for Cryptosporidium infections in
humans [93, 94].
Giardiasis
Giardiasis is another common cause of acute and chronic
diarrhea in humans and domestic animals. Among six
known Giardia species, only G. duodenalis is responsible
for infecting humans and most mammals. At least eight
major genotypes (assemblages A–H) are known in this
species. Of these, only assemblages A and B are zoonotic
genotypes capable of infecting humans and other mam-
mals [95]. Globally, about 200 million people suffer from
symptomatic giardiasis. Children in developing countries
are particularly at risk, with a prevalence of 20–30 %, as
compared to the rate of 2–3 % in high-income countries
[88]. In China, according to the first national survey
conducted in 1992, giardiasis was endemic across the
whole country with a mean infection rate of 2.5 %.
The prevalence of giardiasis had declined significantly
by the time the second national survey was under-
taken in 2004 (e.g. from 3.85 % to 1.00 % in Zhejiang
province) [47, 48, 91]. However, it was still common
in children and in some underprivileged communities.
Giardia oocysts were found in 32 of 762 school chil-
dren (4.2 %) in Turpan area, Xinjiang Uygur in 2012
[96]. The prevalence of G. duodenalis infection in
two rural villages of Anhui was 3.6 % (28/769) in
2008 [97].
Toxoplasmosis
Toxoplasmosis is caused by the obligate intracellular
protozoan Toxoplasma gondii. Nearly one-third of the
global human population is chronically infected. The
disease also causes enormous economic losses to the
livestock industry [98]. In China, the prevalence of T.
gondii is relatively low compared with that in some
European countries, but it appears to have increased
over the past decade. The second national survey (2004)
found a prevalence of 7.9 %, which was significantly
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higher than the 5.2 % prevalence found in the first
national survey in 1992. Prevalence rates among some
minority ethnic groups such as Miao (25.4 %), Buyi
(25.3 %), and Mongol (17.1 %) were particularly high,
perhaps as a consequence of these groups’ habit of
eating raw or partially cooked meat [48, 99]. Seroepide-
miological surveys in recent years showed that the
prevalence of T. gondii is about 10–20 %, with a signifi-
cantly higher prevalence rate in cancer patients (35.6 %)
[100–102]. The prevalence of T. gondii in livestock is
also high (about 15–31 %) [99]. The Chinese 1 (ToxoDB
#9) genotype is the dominant genotype and exhibits a
virulence similar to that of Type 1, which is predominant
in North America and Europe [99].
Emerging parasitic diseases of poverty
Angiostrongyliasis
Angiostrongyliasis, an emerging foodborne disease, is
caused by Angiostrongylus cantonensis, which was first
discovered in rats in Guangzhou in 1935 [103]. Now, it
is endemic in Southeast Asia, Australia, the Caribbean,
and the Pacific Islands. More than 2800 cases have been
documented worldwide [104, 105]. In the past decades,
the number of cases has sharply increased with several
outbreaks reported. Between 1997 and 2011, several
angiostrongyliasis outbreaks have been reported in
China [106–108]. The largest outbreak occurred in
Beijing city in 2006, which involved 160 cases [106]. Of
them, 100 were hospitalized and four died. Investigators
found that 75.1 % of those infected had eaten raw
snails (Pomacea canaliculata and Achatina fulica),
which was an important risk factor [106]. Food safety
must be improved to interrupt the transmission of
this parasitic disease.
Perspectives for better control
Although China has made tremendous achievements in
the prevention, control, and elimination of human para-
sitic diseases over 60 years of unremitting efforts, the
burden of parasitic diseases is still great, especially in
poor rural areas, due to poverty and inequalities in
public services and environmental conditions [7–9].
Because China seeks to further reduce the burden of
parasitic diseases, it is time to reflect on the progress
made so far and what remains to be done. We now
address the challenges and weaknesses in the control of
parasitic diseases of poverty in the country, and outline
the relevant strategies and measures to control them
more effectively.
Poverty
China has undergone rapid and sustained economic
development in the past three decades. However, eco-
nomic development and consequent benefits are not
evenly distributed across the vast geographical area of
China. Western and central regions of the country are
still less developed, the incidence of poverty is far
greater, and health care is less accessible. Additionally,
inadequate hygiene and sanitation, and a limited access
to safe water have also contributed to the higher preva-
lence rates of parasitic diseases of poverty [109–112].
For example, temporal and spatial analysis carried out in
Yunnan province indicated that poverty and malaria are
closely linked: that is, low-income counties commonly
have a high incidence of malaria [13]. Therefore, finan-
cial support for economic development in these counties
is needed to increase the incomes and living standards
of the poor. Secondly, an increase in the number of
public health workers and hospital staff, especially in
poor rural areas, is required. These workers need to be
provided with specific training to equip them to deal
with IDoPs. Thirdly, the basic healthcare coverage needs
to be enhanced and the cost of health care must be
lowered. Finally, provision of safe drinking water and re-
lated essential services must be increased in poor areas.
Environment
Rapid economic development has caused environmental
damage, such as overgrazing and deforestation. Several
large-scale environmental modifications, including the
South-to-North Water Diversion Project (SNWTP) and
the Three Gorges Dam Project (TGDP), have been
implemented in 2002 and in 1994, respectively. These
might aggravate the emergence and spread of parasitic
diseases. For example, both SNWTP and TGDP can en-
hance the transmission of schistosomiasis and snail-borne
trematodiases by enlarging snail habitats [113–115].
Global warming might affect the geographical distri-
butions of vectors such as sandflies and mosquitoes
[114]. Additionally, global warming might also affect
the reproduction and extrinsic incubation period (EIP)
of parasites. For example, the EIP of P. falciparum para-
sites are 26 days at 20 °C and 13 days at 25 °C [116].
Deforestation destroys wildlife habitats, thereby increasing
interactions with humans and the transmission of zoo-
notic diseases, such as AE [81, 117, 118]. China must
embrace the “One World, One Health” initiative to deal
with health problems, including those pertaining to wild
animals. Protection of the environment, as well as sur-
veillance and responses to environmental and climate
changes also need to be strengthened [1].
Globalization and urbanization
Globalization and urbanization have enhanced the mobil-
ity of people [119]. Every year, large numbers of Chinese
people working abroad return home and many foreign
laborers and travelers come to China. These people may
introduce diseases to non-endemic regions of China. For
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example, in recent years, locally-transmitted P. vivax mal-
aria has significantly decreased in prevalence but imported
P. vivax malaria has sharply increased [23]. In the past
three decades, China has undergone the largest-ever
human migration with 260 million people moving from
poor rural areas to the cities. This also has the potential to
promote the spread of parasitic diseases of poverty and
brings great challenges for the detection and control of
epidemics [119]. Therefore, diagnosis and treatment of
infectious diseases in migrants need to be strengthened.
Lifestyle and education
Over the past decades, the prevalence rates of foodborne
parasitic diseases (e.g. angiostrongyliasis, clonorchiasis,
and paragonimiasis) have increased significantly due to
the habit of eating raw or undercooked fish, snails, and
meat [8, 9]. Such dietary habits are traditional and
remain common, such as the widely prevailing habit of
eating raw fish in northeastern and southeastern China
[53]. Traditional agriculture practices, such as the use of
water buffaloes in the fields, also increase the possibility
of parasitic infections [120]. Furthermore, some local
religious beliefs limit the prevention and control of
infectious diseases. In the echinococcosis-endemic west
of China, killing of stray dogs (the definitive host of E.
granulosus) is not possible due to religious beliefs [86].
Knowledge of, attitudes towards, and individual responses
in light of this, especially by parents and influential com-
munity members, are crucial factors for preventing and
controlling parasitic diseases. However, people in poor
rural areas, especially children, have a low awareness of
parasitic diseases [85, 121]. Health education packages,
aiming to improve knowledge and awareness and change
in hygiene behavior, are an effective way to prevent para-
sitic diseases [122]. Therefore, health education should be
extensively promoted, especially in poor regions.
Diagnosis and drugs
Although low-intensity infections with parasites are often
asymptomatic, they can damage human health and even
cause death when left untreated. However, poor awareness
of asymptomatic infections, as well as the current lack of
sensitive and specific tools for early diagnosis, might
accelerate the spread of parasitic diseases of poverty. For
example, there is a lack of sensitive tools for the identifica-
tion of asymptomatic malaria patients and for early diag-
nosis of echinococcosis [120]. Besides this, some of the
available diagnostic tools are expensive, restricting their
use in large-scale endemic surveys (i.e. diagnostic tests
for S. japonicum infection) [120, 123]. Furthermore, pro-
longed use of certain drugs for treatment of some parasitic
diseases might make parasites drug-resistant. An example
of this is the emergence of chloroquine resistance in P.
falciparum [24]. Therefore, in addition to rational use of
antiparasitic drugs, a thorough understanding of the
life cycles, biology, and gene functions of parasites is
needed to develop sensitive and high-throughput di-
agnostic methods, as well as low-cost and effective
drugs and vaccines.
Surveillance-response systems
Through persistent efforts, China achieved the eli-
mination of lymphatic filariasis in 2007. Campaigns
against other parasitic diseases such as schistosomiasis
and leishmaniasis have moved from the control stage
to the elimination stage, with only sporadic cases
occurring [7, 124, 125]. Sparse data on some parasitic
IDoPs are a key obstacle to controlling and eliminat-
ing these diseases. Effective and timely surveillance-
response systems characterized by reliable information
on the prevalence and spatiotemporal distribution of
diseases, coupled with rapid-response capability to
dispose of emerging threats, provide the final key step
to achieving effective prevention, control, and eli-
mination of IDoPs [126–128]. Due to the complexity
and difficulty of controlling parasitic diseases of pov-
erty, any surveillance-response system should include a
range of elements. First, surveillance of parasitic infec-
tions in frontier regions and poor rural areas should be
strengthened [129]. This includes surveillance in low-
transmission areas where public health interventions
have greatly reduced prevalence of infections. Second,
surveillance data, including data from humans and
animals, should be updated in a timely manner. Third,
effective innovations and new technologies should be
introduced into the surveillance-response systems, such
as geographical information systems, global positioning
systems, and geostatistical modeling. Finally, coordin-
ation between the control of parasitic diseases of pov-
erty in humans and animals, as well as interdisciplinary
and international cooperation must be strengthened
due to the increase in the international transmission of
infectious diseases [129].
Conclusions
Significant progress has been made in the last
60 years to reduce the burden of parasitic diseases
in China. However, considerable challenges remain,
especially in poor rural areas. Fortunately, Chinese
central and local governments have drawn up a
range of control programs and implemented many
integrated control strategies to prevent, control, and
eliminate parasitic diseases of poverty. Some control
strategies can serve as brilliant models for other de-
veloping countries, and China is willing to share its
expertise and work with international partners to
achieve the outcomes promoted by the “One World,
One Health” initiative [1].
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